| Chan, Linda |
NCT04644822: Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. |
|
|
| Completed | 3 | 100 | Canada | [18F] PSMA-1007 Injection | Centre for Probe Development and Commercialization, McDougall Scientific Ltd. | Prostate Cancer Recurrent, Recurrent Prostate Cancer | 01/24 | 01/24 | | |
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC). |
|
|
| Completed | 3 | 298 | Europe, Canada, US, RoW | NovoTTF-200M device, Best Standard of Care | NovoCure GmbH | Brain Metastases from Non-small Cell Lung Cancer (NSCLC) | 11/24 | 11/24 | | |
| Completed | N/A | 852 | RoW | POC-cHbA1c testing | The University of Hong Kong, Hospital Authority, Hong Kong, Food and Health Bureau, Hong Kong | Diabetes Mellitus, Pre-diabetes | 12/23 | 12/23 | | |
NCT04552509: TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer |
|
|
| Recruiting | N/A | 167 | US | Stereotactic Body Radiotherapy | Linda Chan, MD | Prostate Cancer | 06/23 | 06/23 | | |
NCT02016248: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer |
|
|
| Recruiting | N/A | 167 | US | Stereotactic Ablative Body Radiotherapy as Monotherapy, Accuray CyberKnife, Stereotactic Ablative Body Radiotherapy as a Boost | MemorialCare Health System | Prostate Cancer | 06/28 | 06/29 | | |
